The new way to show your lens creativity.​Due to over subscription in such a big number, most of the retail investors will be disappointed as they won't get a single lot. We believe a lot is left on the table for the investors by comparing its valuation with other speciality chemical companies. We are positive on the future outlook for the industry as well as the company, so we have recommended subscribing to the issue for long-term as well as for listing gains," Keshav Lahoti, Associate Equity Analyst at Angel Broking said